Robbins G, Vue Y, Rahrmann E, Moriarity B
Med Res Arch. 2025; 12(11).
PMID: 39916749
PMC: 11801376.
DOI: 10.18103/mra.v12i11.6000.
Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z
Cancer Cell Int. 2025; 25(1):29.
PMID: 39885569
PMC: 11783933.
DOI: 10.1186/s12935-025-03659-4.
Rodrigues J, Sarmento B, Leite Pereira C
In Vitro Model. 2025; 1(1):5-27.
PMID: 39872973
PMC: 11756501.
DOI: 10.1007/s44164-022-00008-x.
Zhuang Y, Li X
Medicine (Baltimore). 2025; 104(3):e40240.
PMID: 39833053
PMC: 11749676.
DOI: 10.1097/MD.0000000000040240.
Zhang N, Haizhen Z, Zhang R, Li X
Front Immunol. 2025; 15:1468875.
PMID: 39742274
PMC: 11685004.
DOI: 10.3389/fimmu.2024.1468875.
Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases.
Kapoor S, Gupta M, Sapra L, Kaur T, Srivastava R
Bone Rep. 2024; 23:101809.
PMID: 39497943
PMC: 11532283.
DOI: 10.1016/j.bonr.2024.101809.
3D Tumor-Engineered Model Replicating the Osteosarcoma Stem Cell Niche and Tumor Complexity.
Bassi G, Rossi A, Campodoni E, Sandri M, Sarogni P, Fulle S
ACS Appl Mater Interfaces. 2024; .
PMID: 39353598
PMC: 11492322.
DOI: 10.1021/acsami.4c02567.
The sEVs miR-487a/Notch2/GATA3 axis promotes osteosarcoma lung metastasis by inducing macrophage polarization toward the M2-subtype.
Wang P, Yang L, Dong J, Liu W, Xie F, Lu Y
Cancer Cell Int. 2024; 24(1):301.
PMID: 39217351
PMC: 11365232.
DOI: 10.1186/s12935-024-03488-x.
Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms.
Sergi C
Discov Oncol. 2024; 15(1):358.
PMID: 39154307
PMC: 11330953.
DOI: 10.1007/s12672-024-01240-5.
Modulating tumor-associated macrophage polarization by anti-maRCO mAb exerts anti-osteosarcoma effects through regulating osteosarcoma cell proliferation, migration and apoptosis.
Ding L, Wu L, Cao Y, Wang H, Li D, Chen W
J Orthop Surg Res. 2024; 19(1):453.
PMID: 39085912
PMC: 11290128.
DOI: 10.1186/s13018-024-04950-2.
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies.
Liang H, Cui M, Tu J, Chen X
Front Cell Dev Biol. 2024; 12:1394339.
PMID: 38915446
PMC: 11194413.
DOI: 10.3389/fcell.2024.1394339.
The prognostic value of ubiquitin/ubiquitin-like-related genes along with immune cell infiltration and clinicopathological features in osteosarcoma.
Wen J, Wan L, Chen W, Dong X
J Orthop Surg Res. 2024; 19(1):356.
PMID: 38879525
PMC: 11179372.
DOI: 10.1186/s13018-024-04781-1.
An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis.
Teng J, Wang Y
Sci Rep. 2024; 14(1):13401.
PMID: 38862526
PMC: 11166963.
DOI: 10.1038/s41598-024-54292-6.
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment.
He X, Que L, Yang F, Feng Y, Ren D, Song X
J Bone Oncol. 2024; 46:100604.
PMID: 38765702
PMC: 11101886.
DOI: 10.1016/j.jbo.2024.100604.
Identification and prognostic evaluation of differentially expressed long noncoding RNAs associated with immune infiltration in osteosarcoma.
Wang B, Wang X, Du X, Gao S, Liang B, Yao W
Heliyon. 2024; 10(5):e27023.
PMID: 38463807
PMC: 10920385.
DOI: 10.1016/j.heliyon.2024.e27023.
The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
Liu B, Liu X, Wang G, Chen Y
Sci Rep. 2024; 14(1):5184.
PMID: 38431660
PMC: 10908810.
DOI: 10.1038/s41598-024-55890-0.
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.
Al-Ansari N, Samuel S, Busselberg D
Biomolecules. 2024; 14(2).
PMID: 38397382
PMC: 10886489.
DOI: 10.3390/biom14020145.
A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma.
Yu B, Geng C, Wu Z, Zhang Z, Zhang A, Yang Z
Sci Rep. 2024; 14(1):1308.
PMID: 38225273
PMC: 10789798.
DOI: 10.1038/s41598-023-49770-2.
What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance.
Qi J, Liu S, Zhang Z
Cancer Cell Int. 2024; 24(1):31.
PMID: 38218960
PMC: 10788037.
DOI: 10.1186/s12935-024-03216-5.
Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways.
Wu C, Tan J, Shen H, Deng C, Kleber C, Osterhoff G
J Biomed Sci. 2024; 31(1):4.
PMID: 38212768
PMC: 10785352.
DOI: 10.1186/s12929-024-00999-7.